RedHill Biopharma Ltd. ADR (RDHL)
Market Closed
12 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 21
+0.01
+0.43%
$
3.63M Market Cap
- P/E Ratio
- Div Yield
35,979 Volume
- Eps
$ 1.2
Previous Close Day Range
1.2 1.22
Year Range
1.01 7.44
Want to track RDHL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes
On Monday, RedHill Biopharma Ltd. RDHL released results from multiple in vivo studies, undertaken by RedHill's partner, Apogee Biotechnology Corporation.
Benzinga | 1 year ago
Why Is RedHill Biopharma (RDHL) Stock Up 75% Today?
One of today's biggest movers in the biotech sector is RedHill Biopharma (NASDAQ: RDHL ), a little-known specialty player in the space focusing on gastrointestinal and infectious diseases. Today, RDHL stock is up more than 75% in early afternoon trading on an announcement from the company that it has seen positive results for a key Phase 3 study.
Investorplace | 1 year ago
2025 © Marketlog. All Rights Reserved.
